These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 30934532)

  • 1. Correction: Kutlushina, A., et al. Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures. Molecules, 2018, 23, 3094.
    Kutlushina A; Khakimova A; Madzhidov T; Polishchuk P
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30934532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures.
    Kutlushina A; Khakimova A; Madzhidov T; Polishchuk P
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Xie, H.; et al. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Int. J. Mol. Sci. 2014, 15, 20927-20947.
    Xie H; Qiu K; Xie X
    Int J Mol Sci; 2015 Mar; 16(3):5072-5. PubMed ID: 25751723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives.
    Gade DR; Kunala P; Raavi D; Reddy PK; Prasad RV
    J Recept Signal Transduct Res; 2015 Apr; 35(2):189-201. PubMed ID: 25140764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of FIXa inhibitors by combination of pharmacophore modeling, molecular docking, and 3D-QSAR modeling.
    Li P; Peng J; Zhou Y; Li Y; Liu X; Wang L; Zuo Z
    J Recept Signal Transduct Res; 2018 Jun; 38(3):213-224. PubMed ID: 29724133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore, 3D-QSAR Models and Dynamic Simulation of 1,4-Benzothiazines for Colorectal Cancer Treatment.
    Rai A; Raj V; Aboumanei MH; Singh AK; Keshari AK; Verma SP; Saha S
    Comb Chem High Throughput Screen; 2017; 20(8):658-674. PubMed ID: 28486913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
    Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
    Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.
    Zou J; Xie HZ; Yang SY; Chen JJ; Ren JX; Wei YQ
    J Mol Graph Model; 2008 Nov; 27(4):430-8. PubMed ID: 18786843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling.
    Vuorinen A; Schuster D
    Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations.
    Wieder M; Garon A; Perricone U; Boresch S; Seidel T; Almerico AM; Langer T
    J Chem Inf Model; 2017 Feb; 57(2):365-385. PubMed ID: 28072524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.
    Kumar SP
    J Mol Model; 2018 Sep; 24(10):282. PubMed ID: 30220049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces.
    Mortier J; Dhakal P; Volkamer A
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
    Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
    Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.
    Ananthula RS; Ravikumar M; Pramod AB; Madala KK; Mahmood SK
    J Mol Graph Model; 2008 Nov; 27(4):546-57. PubMed ID: 18993099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors.
    Tripuraneni NS; Azam MA
    J Theor Biol; 2016 Apr; 394():117-126. PubMed ID: 26804643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.
    Lee YH; Yi GS
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
    Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
    Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
    Bhatt HG; Patel PK
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of pharmacophore similarity-based quantitative activity hypothesis and its applicability domain: applied on a diverse data-set of HIV-1 integrase inhibitors.
    Kumar SP; Jasrai YT; Mehta VP; Pandya HA
    J Biomol Struct Dyn; 2015; 33(4):706-22. PubMed ID: 24735019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.